Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Guanosine-Rich Oligonucleotide Integrase Inhibitors

  • Read more about Guanosine-Rich Oligonucleotide Integrase Inhibitors
US Application 09/429,130
Filed on 1999-10-28

High Speed Parallel Molecular Nucleic Acid Sequencing

  • Read more about High Speed Parallel Molecular Nucleic Acid Sequencing
Patent Cooperation Treaty
PCT/US2000/023736
Filed on 2000-08-29

T-Cell Receptor Alternate Reading Frame Protein, (TARP) And Uses Thereof

  • Read more about T-Cell Receptor Alternate Reading Frame Protein, (TARP) And Uses Thereof
Patent Cooperation Treaty
PCT/US2000/019039
Filed on 2000-07-12

METHODS AND COMPOSITIONS OF CHEMOKINE-TUMOR ANTIGEN FUSION PROTEINS AS CANCER VACCINES

  • Read more about METHODS AND COMPOSITIONS OF CHEMOKINE-TUMOR ANTIGEN FUSION PROTEINS AS CANCER VACCINES
US Patent 6,562,347
Filed on 2000-09-12

Protocol And Software For Multiplex Real Time PCR Quantification Based On The Different Melting Temperatures Of Amplicons

  • Read more about Protocol And Software For Multiplex Real Time PCR Quantification Based On The Different Melting Temperatures Of Amplicons
US Application 10/658,602
Filed on 2003-09-08

Polypeptides that Bind HIV gp120 and Related Nucleic Acids, Antibodies, Compositions, and Methods of Use

  • Read more about Polypeptides that Bind HIV gp120 and Related Nucleic Acids, Antibodies, Compositions, and Methods of Use
Patent Cooperation Treaty
PCT/US2000/023505
Filed on 2000-08-25

Mutant of RAD51 Gene and Its Use in the Diagnosis of Predisposition to Breast Cancer

  • Read more about Mutant of RAD51 Gene and Its Use in the Diagnosis of Predisposition to Breast Cancer
Patent Cooperation Treaty
PCT/US00/024786
Filed on 2000-09-08

Determination of AM-Binding Proteins and the Association of Adrenomedullin (AM) Therewith

  • Read more about Determination of AM-Binding Proteins and the Association of Adrenomedullin (AM) Therewith
Patent Cooperation Treaty
PCT/US00/24722
Filed on 2000-09-08

CDNA ENCODING A GENE BOG (B5T OVER-EXPRESSED GENE) AND ITS PROTEIN PRODUCT

  • Read more about CDNA ENCODING A GENE BOG (B5T OVER-EXPRESSED GENE) AND ITS PROTEIN PRODUCT
US Patent 6,727,079
Filed on 2000-08-11

DLC-1 Gene Deleted in Cancers

  • Read more about DLC-1 Gene Deleted in Cancers
US Patent 6,897,018
Filed on 2000-08-23

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1501
  • Page 1502
  • Page 1503
  • Page 1504
  • Page 1505
  • Page 1506
  • Page 1507
  • Page 1508
  • Page 1509
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health